Global Human Coagulation Factor VIII Sales Market Report 2021

Publisher Name :
Date: 26-Mar-2021
No. of pages: 147
Inquire Before Buying

The global Human Coagulation Factor VIII market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Coagulation Factor VIII market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

- Recombinant Factor VIII

- Plasma-derived Factor VIII

Segment by Application

- Hemophilia A

- Spontanous / Trauma

- Surgical

- Other

The Human Coagulation Factor VIII market is analysed and market size information is provided by regions (countries). Segment by Application, the Human Coagulation Factor VIII market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company

- Shire (Baxter)

- Bayer

- CSL

- Pfizer

- Grifols

- Biogen

- Octapharma

- NovoNordisk

- Greencross

- Kedrion

- BPL

- Hualan Bio

- RAAS

Global Human Coagulation Factor VIII Sales Market Report 2021

Table of Contents
1 Human Coagulation Factor VIII Market Overview
1.1 Human Coagulation Factor VIII Product Scope
1.2 Human Coagulation Factor VIII Segment by Type
1.2.1 Global Human Coagulation Factor VIII Sales by Type (2016 & 2021 & 2027)
1.2.2 Recombinant Factor VIII
1.2.3 Plasma-derived Factor VIII
1.3 Human Coagulation Factor VIII Segment by Application
1.3.1 Global Human Coagulation Factor VIII Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hemophilia A
1.3.3 Spontanous / Trauma
1.3.4 Surgical
1.3.5 Other
1.4 Human Coagulation Factor VIII Market Estimates and Forecasts (2016-2027)
1.4.1 Global Human Coagulation Factor VIII Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Human Coagulation Factor VIII Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Human Coagulation Factor VIII Price Trends (2016-2027)
2 Human Coagulation Factor VIII Estimates and Forecasts by Region
2.1 Global Human Coagulation Factor VIII Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Human Coagulation Factor VIII Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Human Coagulation Factor VIII Sales Market Share by Region (2016-2021)
2.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Region (2016-2021)
2.3 Global Human Coagulation Factor VIII Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Human Coagulation Factor VIII Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Human Coagulation Factor VIII Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Human Coagulation Factor VIII Estimates and Projections (2016-2027)
2.4.2 Europe Human Coagulation Factor VIII Estimates and Projections (2016-2027)
2.4.3 China Human Coagulation Factor VIII Estimates and Projections (2016-2027)
2.4.4 Japan Human Coagulation Factor VIII Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Human Coagulation Factor VIII Estimates and Projections (2016-2027)
2.4.6 India Human Coagulation Factor VIII Estimates and Projections (2016-2027)
3 Global Human Coagulation Factor VIII Competition Landscape by Players
3.1 Global Top Human Coagulation Factor VIII Players by Sales (2016-2021)
3.2 Global Top Human Coagulation Factor VIII Players by Revenue (2016-2021)
3.3 Global Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Coagulation Factor VIII as of 2020)
3.4 Global Human Coagulation Factor VIII Average Price by Company (2016-2021)
3.5 Manufacturers Human Coagulation Factor VIII Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Human Coagulation Factor VIII Market Size by Type
4.1 Global Human Coagulation Factor VIII Historic Market Review by Type (2016-2021)
4.1.1 Global Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
4.1.2 Global Human Coagulation Factor VIII Revenue Market Share by Type (2016-2021)
4.1.3 Global Human Coagulation Factor VIII Price by Type (2016-2021)
4.2 Global Human Coagulation Factor VIII Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Human Coagulation Factor VIII Sales Forecast by Type (2022-2027)
4.2.2 Global Human Coagulation Factor VIII Revenue Forecast by Type (2022-2027)
4.2.3 Global Human Coagulation Factor VIII Price Forecast by Type (2022-2027)
5 Global Human Coagulation Factor VIII Market Size by Application
5.1 Global Human Coagulation Factor VIII Historic Market Review by Application (2016-2021)
5.1.1 Global Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
5.1.2 Global Human Coagulation Factor VIII Revenue Market Share by Application (2016-2021)
5.1.3 Global Human Coagulation Factor VIII Price by Application (2016-2021)
5.2 Global Human Coagulation Factor VIII Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Human Coagulation Factor VIII Sales Forecast by Application (2022-2027)
5.2.2 Global Human Coagulation Factor VIII Revenue Forecast by Application (2022-2027)
5.2.3 Global Human Coagulation Factor VIII Price Forecast by Application (2022-2027)
6 North America Human Coagulation Factor VIII Market Facts & Figures
6.1 North America Human Coagulation Factor VIII Sales by Company
6.1.1 North America Human Coagulation Factor VIII Sales by Company (2016-2021)
6.1.2 North America Human Coagulation Factor VIII Revenue by Company (2016-2021)
6.2 North America Human Coagulation Factor VIII Sales Breakdown by Type
6.2.1 North America Human Coagulation Factor VIII Sales Breakdown by Type (2016-2021)
6.2.2 North America Human Coagulation Factor VIII Sales Breakdown by Type (2022-2027)
6.3 North America Human Coagulation Factor VIII Sales Breakdown by Application
6.3.1 North America Human Coagulation Factor VIII Sales Breakdown by Application (2016-2021)
6.3.2 North America Human Coagulation Factor VIII Sales Breakdown by Application (2022-2027)
7 Europe Human Coagulation Factor VIII Market Facts & Figures
7.1 Europe Human Coagulation Factor VIII Sales by Company
7.1.1 Europe Human Coagulation Factor VIII Sales by Company (2016-2021)
7.1.2 Europe Human Coagulation Factor VIII Revenue by Company (2016-2021)
7.2 Europe Human Coagulation Factor VIII Sales Breakdown by Type
7.2.1 Europe Human Coagulation Factor VIII Sales Breakdown by Type (2016-2021)
7.2.2 Europe Human Coagulation Factor VIII Sales Breakdown by Type (2022-2027)
7.3 Europe Human Coagulation Factor VIII Sales Breakdown by Application
7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)
8 China Human Coagulation Factor VIII Market Facts & Figures
8.1 China Human Coagulation Factor VIII Sales by Company
8.1.1 China Human Coagulation Factor VIII Sales by Company (2016-2021)
8.1.2 China Human Coagulation Factor VIII Revenue by Company (2016-2021)
8.2 China Human Coagulation Factor VIII Sales Breakdown by Type
8.2.1 China Human Coagulation Factor VIII Sales Breakdown by Type (2016-2021)
8.2.2 China Human Coagulation Factor VIII Sales Breakdown by Type (2022-2027)
8.3 China Human Coagulation Factor VIII Sales Breakdown by Application
8.3.1 China 313 Sales Breakdown by Application (2016-2021)
8.3.2 China 313 Sales Breakdown by Application (2022-2027)
9 Japan Human Coagulation Factor VIII Market Facts & Figures
9.1 Japan Human Coagulation Factor VIII Sales by Company
9.1.1 Japan Human Coagulation Factor VIII Sales by Company (2016-2021)
9.1.2 Japan Human Coagulation Factor VIII Revenue by Company (2016-2021)
9.2 Japan Human Coagulation Factor VIII Sales Breakdown by Type
9.2.1 Japan Human Coagulation Factor VIII Sales Breakdown by Type (2016-2021)
9.2.2 Japan Human Coagulation Factor VIII Sales Breakdown by Type (2022-2027)
9.3 Japan Human Coagulation Factor VIII Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Human Coagulation Factor VIII Market Facts & Figures
10.1 Southeast Asia Human Coagulation Factor VIII Sales by Company
10.1.1 Southeast Asia Human Coagulation Factor VIII Sales by Company (2016-2021)
10.1.2 Southeast Asia Human Coagulation Factor VIII Revenue by Company (2016-2021)
10.2 Southeast Asia Human Coagulation Factor VIII Sales Breakdown by Type
10.2.1 Southeast Asia Human Coagulation Factor VIII Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Human Coagulation Factor VIII Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Human Coagulation Factor VIII Sales Breakdown by Application
10.3.1 Southeast Asia Kg Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia Kg Sales Breakdown by Application (2022-2027)
11 India Human Coagulation Factor VIII Market Facts & Figures
11.1 India Human Coagulation Factor VIII Sales by Company
11.1.1 India Human Coagulation Factor VIII Sales by Company (2016-2021)
11.1.2 India Human Coagulation Factor VIII Revenue by Company (2016-2021)
11.2 India Human Coagulation Factor VIII Sales Breakdown by Type
11.2.1 India Human Coagulation Factor VIII Sales Breakdown by Type (2016-2021)
11.2.2 India Human Coagulation Factor VIII Sales Breakdown by Type (2022-2027)
11.3 India Human Coagulation Factor VIII Sales Breakdown by Application
11.3.1 India Human Coagulation Factor VIII Sales Breakdown by Application (2016-2021)
11.3.2 India Human Coagulation Factor VIII Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Human Coagulation Factor VIII Business
12.1 Shire (Baxter)
12.1.1 Shire (Baxter) Corporation Information
12.1.2 Shire (Baxter) Business Overview
12.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Shire (Baxter) Human Coagulation Factor VIII Products Offered
12.1.5 Shire (Baxter) Recent Development
12.2 Bayer
12.2.1 Bayer Corporation Information
12.2.2 Bayer Business Overview
12.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bayer Human Coagulation Factor VIII Products Offered
12.2.5 Bayer Recent Development
12.3 CSL
12.3.1 CSL Corporation Information
12.3.2 CSL Business Overview
12.3.3 CSL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.3.4 CSL Human Coagulation Factor VIII Products Offered
12.3.5 CSL Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Pfizer Human Coagulation Factor VIII Products Offered
12.4.5 Pfizer Recent Development
12.5 Grifols
12.5.1 Grifols Corporation Information
12.5.2 Grifols Business Overview
12.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Grifols Human Coagulation Factor VIII Products Offered
12.5.5 Grifols Recent Development
12.6 Biogen
12.6.1 Biogen Corporation Information
12.6.2 Biogen Business Overview
12.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Biogen Human Coagulation Factor VIII Products Offered
12.6.5 Biogen Recent Development
12.7 Octapharma
12.7.1 Octapharma Corporation Information
12.7.2 Octapharma Business Overview
12.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Octapharma Human Coagulation Factor VIII Products Offered
12.7.5 Octapharma Recent Development
12.8 NovoNordisk
12.8.1 NovoNordisk Corporation Information
12.8.2 NovoNordisk Business Overview
12.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.8.4 NovoNordisk Human Coagulation Factor VIII Products Offered
12.8.5 NovoNordisk Recent Development
12.9 Greencross
12.9.1 Greencross Corporation Information
12.9.2 Greencross Business Overview
12.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Greencross Human Coagulation Factor VIII Products Offered
12.9.5 Greencross Recent Development
12.10 Kedrion
12.10.1 Kedrion Corporation Information
12.10.2 Kedrion Business Overview
12.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Kedrion Human Coagulation Factor VIII Products Offered
12.10.5 Kedrion Recent Development
12.11 BPL
12.11.1 BPL Corporation Information
12.11.2 BPL Business Overview
12.11.3 BPL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.11.4 BPL Human Coagulation Factor VIII Products Offered
12.11.5 BPL Recent Development
12.12 Hualan Bio
12.12.1 Hualan Bio Corporation Information
12.12.2 Hualan Bio Business Overview
12.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Hualan Bio Human Coagulation Factor VIII Products Offered
12.12.5 Hualan Bio Recent Development
12.13 RAAS
12.13.1 RAAS Corporation Information
12.13.2 RAAS Business Overview
12.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.13.4 RAAS Human Coagulation Factor VIII Products Offered
12.13.5 RAAS Recent Development
13 Human Coagulation Factor VIII Manufacturing Cost Analysis
13.1 Human Coagulation Factor VIII Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Coagulation Factor VIII
13.4 Human Coagulation Factor VIII Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Coagulation Factor VIII Distributors List
14.3 Human Coagulation Factor VIII Customers
15 Market Dynamics
15.1 Human Coagulation Factor VIII Market Trends
15.2 Human Coagulation Factor VIII Drivers
15.3 Human Coagulation Factor VIII Market Challenges
15.4 Human Coagulation Factor VIII Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Human Coagulation Factor VIII Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Human Coagulation Factor VIII Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Human Coagulation Factor VIII Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Human Coagulation Factor VIII Sales (Kg) by Region (2016-2021)
Table 5. Global Human Coagulation Factor VIII Sales Market Share by Region (2016-2021)
Table 6. Global Human Coagulation Factor VIII Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Human Coagulation Factor VIII Revenue Share by Region (2016-2021)
Table 8. Global Human Coagulation Factor VIII Sales (Kg) Forecast by Region (2022-2027)
Table 9. Global Human Coagulation Factor VIII Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Human Coagulation Factor VIII Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Human Coagulation Factor VIII Revenue Share Forecast by Region (2022-2027)
Table 12. Global Human Coagulation Factor VIII Sales (Kg) of Key Companies (2016-2021)
Table 13. Global Human Coagulation Factor VIII Sales Share by Company (2016-2021)
Table 14. Global Human Coagulation Factor VIII Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Human Coagulation Factor VIII Revenue Share by Company (2016-2021)
Table 16. Global Human Coagulation Factor VIII by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Coagulation Factor VIII as of 2020)
Table 17. Global Human Coagulation Factor VIII Average Price (USD/Kg) of Key Company (2016-2021)
Table 18. Manufacturers Human Coagulation Factor VIII Manufacturing Sites and Area Served
Table 19. Manufacturers Human Coagulation Factor VIII Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Human Coagulation Factor VIII Sales (Kg) by Type (2016-2021)
Table 22. Global Human Coagulation Factor VIII Sales Share by Type (2016-2021)
Table 23. Global Human Coagulation Factor VIII Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Human Coagulation Factor VIII Price (USD/Kg) by Type (2016-2021)
Table 25. Global Human Coagulation Factor VIII Sales Share by Type (2022-2027)
Table 26. Global Human Coagulation Factor VIII Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Human Coagulation Factor VIII Revenue Share by Type (2022-2027)
Table 28. Global Human Coagulation Factor VIII Price (USD/Kg) by Type (2022-2027)
Table 29. Global Human Coagulation Factor VIII Sales (Kg) by Application (2016-2021)
Table 30. Global Human Coagulation Factor VIII Sales Share by Application (2016-2021)
Table 31. Global Human Coagulation Factor VIII Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Human Coagulation Factor VIII Price (USD/Kg) by Application (2016-2021)
Table 33. Global Human Coagulation Factor VIII Sales (Kg) by Application (2022-2027)
Table 34. Global Human Coagulation Factor VIII Sales Share by Application (2022-2027)
Table 35. Global Human Coagulation Factor VIII Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Human Coagulation Factor VIII Revenue Share by Application (2022-2027)
Table 37. Global Human Coagulation Factor VIII Price (USD/Kg) by Application (2022-2027)
Table 38. North America Human Coagulation Factor VIII Sales (Kg) by Company (2016-2021)
Table 39. North America Human Coagulation Factor VIII Sales Market Share by Company (2016-2021)
Table 40. North America Human Coagulation Factor VIII Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Human Coagulation Factor VIII Revenue Market Share by Company (2016-2021)
Table 42. North America Human Coagulation Factor VIII Sales by Type (2016-2021) & (Kg)
Table 43. North America Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
Table 44. North America Human Coagulation Factor VIII Sales by Type (2022-2027) & (Kg)
Table 45. North America Human Coagulation Factor VIII Sales Market Share by Type (2022-2027)
Table 46. North America Human Coagulation Factor VIII Sales by Application (2016-2021) & (Kg)
Table 47. North America Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
Table 48. North America Human Coagulation Factor VIII Sales by Application (2022-2027) & (Kg)
Table 49. North America Human Coagulation Factor VIII Sales Market Share by Application (2022-2027)
Table 50. Europe Human Coagulation Factor VIII Sales (Kg) by Company (2016-2021)
Table 51. Europe Human Coagulation Factor VIII Sales Market Share by Company (2016-2021)
Table 52. Europe Human Coagulation Factor VIII Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Human Coagulation Factor VIII Revenue Market Share by Company (2016-2021)
Table 54. Europe Human Coagulation Factor VIII Sales by Type (2016-2021) & (Kg)
Table 55. Europe Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
Table 56. Europe Human Coagulation Factor VIII Sales by Type (2022-2027) & (Kg)
Table 57. Europe Human Coagulation Factor VIII Sales Market Share by Type (2022-2027)
Table 58. Europe Human Coagulation Factor VIII Sales by Application (2016-2021) & (Kg)
Table 59. Europe Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
Table 60. Europe Human Coagulation Factor VIII Sales by Application (2022-2027) & (Kg)
Table 61. Europe Human Coagulation Factor VIII Sales Market Share by Application (2022-2027)
Table 62. China Human Coagulation Factor VIII Sales (Kg) by Company (2016-2021)
Table 63. China Human Coagulation Factor VIII Sales Market Share by Company (2016-2021)
Table 64. China Human Coagulation Factor VIII Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Human Coagulation Factor VIII Revenue Market Share by Company (2016-2021)
Table 66. China Human Coagulation Factor VIII Sales by Type (2016-2021) & (Kg)
Table 67. China Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
Table 68. China Human Coagulation Factor VIII Sales by Type (2022-2027) & (Kg)
Table 69. China Human Coagulation Factor VIII Sales Market Share by Type (2022-2027)
Table 70. China Human Coagulation Factor VIII Sales by Application (2016-2021) & (Kg)
Table 71. China Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
Table 72. China Human Coagulation Factor VIII Sales by Application (2022-2027) & (Kg)
Table 73. China Human Coagulation Factor VIII Sales Market Share by Application (2022-2027)
Table 74. Japan Human Coagulation Factor VIII Sales (Kg) by Company (2016-2021)
Table 75. Japan Human Coagulation Factor VIII Sales Market Share by Company (2016-2021)
Table 76. Japan Human Coagulation Factor VIII Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Human Coagulation Factor VIII Revenue Market Share by Company (2016-2021)
Table 78. Japan Human Coagulation Factor VIII Sales by Type (2016-2021) & (Kg)
Table 79. Japan Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
Table 80. Japan Human Coagulation Factor VIII Sales by Type (2022-2027) & (Kg)
Table 81. Japan Human Coagulation Factor VIII Sales Market Share by Type (2022-2027)
Table 82. Japan Human Coagulation Factor VIII Sales by Application (2016-2021) & (Kg)
Table 83. Japan Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
Table 84. Japan Human Coagulation Factor VIII Sales by Application (2022-2027) & (Kg)
Table 85. Japan Human Coagulation Factor VIII Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Human Coagulation Factor VIII Sales (Kg) by Company (2016-2021)
Table 87. Southeast Asia Human Coagulation Factor VIII Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Human Coagulation Factor VIII Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Human Coagulation Factor VIII Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Human Coagulation Factor VIII Sales by Type (2016-2021) & (Kg)
Table 91. Southeast Asia Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Human Coagulation Factor VIII Sales by Type (2022-2027) & (Kg)
Table 93. Southeast Asia Human Coagulation Factor VIII Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Human Coagulation Factor VIII Sales by Application (2016-2021) & (Kg)
Table 95. Southeast Asia Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Human Coagulation Factor VIII Sales by Application (2022-2027) & (Kg)
Table 97. Southeast Asia Human Coagulation Factor VIII Sales Market Share by Application (2022-2027)
Table 98. India Human Coagulation Factor VIII Sales (Kg) by Company (2016-2021)
Table 99. India Human Coagulation Factor VIII Sales Market Share by Company (2016-2021)
Table 100. India Human Coagulation Factor VIII Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Human Coagulation Factor VIII Revenue Market Share by Company (2016-2021)
Table 102. India Human Coagulation Factor VIII Sales by Type (2016-2021) & (Kg)
Table 103. India Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
Table 104. India Human Coagulation Factor VIII Sales by Type (2022-2027) & (Kg)
Table 105. India Human Coagulation Factor VIII Sales Market Share by Type (2022-2027)
Table 106. India Human Coagulation Factor VIII Sales by Application (2016-2021) & (Kg)
Table 107. India Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
Table 108. India Human Coagulation Factor VIII Sales by Application (2022-2027) & (Kg)
Table 109. India Human Coagulation Factor VIII Sales Market Share by Application (2022-2027)
Table 110. Shire (Baxter) Corporation Information
Table 111. Shire (Baxter) Description and Business Overview
Table 112. Shire (Baxter) Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 113. Shire (Baxter) Human Coagulation Factor VIII Product
Table 114. Shire (Baxter) Recent Development
Table 115. Bayer Corporation Information
Table 116. Bayer Description and Business Overview
Table 117. Bayer Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. Bayer Human Coagulation Factor VIII Product
Table 119. Bayer Recent Development
Table 120. CSL Corporation Information
Table 121. CSL Description and Business Overview
Table 122. CSL Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 123. CSL Human Coagulation Factor VIII Product
Table 124. CSL Recent Development
Table 125. Pfizer Corporation Information
Table 126. Pfizer Description and Business Overview
Table 127. Pfizer Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 128. Pfizer Human Coagulation Factor VIII Product
Table 129. Pfizer Recent Development
Table 130. Grifols Corporation Information
Table 131. Grifols Description and Business Overview
Table 132. Grifols Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 133. Grifols Human Coagulation Factor VIII Product
Table 134. Grifols Recent Development
Table 135. Biogen Corporation Information
Table 136. Biogen Description and Business Overview
Table 137. Biogen Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 138. Biogen Human Coagulation Factor VIII Product
Table 139. Biogen Recent Development
Table 140. Octapharma Corporation Information
Table 141. Octapharma Description and Business Overview
Table 142. Octapharma Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 143. Octapharma Human Coagulation Factor VIII Product
Table 144. Octapharma Recent Development
Table 145. NovoNordisk Corporation Information
Table 146. NovoNordisk Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 147. NovoNordisk Description and Business Overview
Table 148. NovoNordisk Human Coagulation Factor VIII Product
Table 149. NovoNordisk Recent Development
Table 150. Greencross Corporation Information
Table 151. Greencross Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 152. Greencross Description and Business Overview
Table 153. Greencross Human Coagulation Factor VIII Product
Table 154. Greencross Recent Development
Table 155. Kedrion Corporation Information
Table 156. Kedrion Description and Business Overview
Table 157. Kedrion Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 158. Kedrion Human Coagulation Factor VIII Product
Table 159. Kedrion Recent Development
Table 160. BPL Corporation Information
Table 161. BPL Description and Business Overview
Table 162. BPL Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 163. BPL Human Coagulation Factor VIII Product
Table 164. BPL Recent Development
Table 165. Hualan Bio Corporation Information
Table 166. Hualan Bio Description and Business Overview
Table 167. Hualan Bio Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 168. Hualan Bio Human Coagulation Factor VIII Product
Table 169. Hualan Bio Recent Development
Table 170. RAAS Corporation Information
Table 171. RAAS Description and Business Overview
Table 172. RAAS Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 173. RAAS Human Coagulation Factor VIII Product
Table 174. RAAS Recent Development
Table 175. Production Base and Market Concentration Rate of Raw Material
Table 176. Key Suppliers of Raw Materials
Table 177. Human Coagulation Factor VIII Distributors List
Table 178. Human Coagulation Factor VIII Customers List
Table 179. Human Coagulation Factor VIII Market Trends
Table 180. Human Coagulation Factor VIII Market Drivers
Table 181. Human Coagulation Factor VIII Market Challenges
Table 182. Human Coagulation Factor VIII Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Coagulation Factor VIII Product Picture
Figure 2. Global Human Coagulation Factor VIII Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Human Coagulation Factor VIII Sales Market Share by Application in 2021 & 2027
Figure 6. Hemophilia A Examples
Figure 7. Spontanous / Trauma Examples
Figure 8. Surgical Examples
Figure 9. Other Examples
Figure 10. Global Human Coagulation Factor VIII Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Human Coagulation Factor VIII Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Human Coagulation Factor VIII Sales (Kg) Growth Rate (2016-2027)
Figure 13. Global Human Coagulation Factor VIII Price Trends Growth Rate (2016-2027) (USD/Kg)
Figure 14. Global Human Coagulation Factor VIII Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Human Coagulation Factor VIII Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Human Coagulation Factor VIII Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Human Coagulation Factor VIII Sales (Kg) Growth Rate (2016-2027)
Figure 18. Europe Human Coagulation Factor VIII Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Human Coagulation Factor VIII Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Human Coagulation Factor VIII Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Human Coagulation Factor VIII Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Human Coagulation Factor VIII Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Human Coagulation Factor VIII Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Human Coagulation Factor VIII Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Human Coagulation Factor VIII Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Human Coagulation Factor VIII Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Human Coagulation Factor VIII Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Human Coagulation Factor VIII Players Market Share by Revenue in Human Coagulation Factor VIII: 2016 & 2020
Figure 29. Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tie
  • Global Human Coagulation Factor VII Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 83
    According to our LPI (LP Information) latest study, the global Human Coagulation Factor VII market size was valued at US$ 2232.8 million in 2023. With growing demand in downstream market, the Human Coagulation Factor VII is forecast to a readjusted size of US$ 4339.6 million by 2030 with a CAGR of 10.0% during review period. The research report highlights the growth potential of the global Human Coagulation Factor VII market. Human Coagulation Factor VII are expected to show stable growt......
  • Global Human Coagulation Factor VIII Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Human Coagulation Factor VIII market size was valued at US$ 10010 million in 2023. With growing demand in downstream market, the Human Coagulation Factor VIII is forecast to a readjusted size of US$ 15590 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Human Coagulation Factor VIII market. Human Coagulation Factor VIII are expected to show stable grow......
  • Global D-Dimer Market Research Report 2023
    Published: 05-Dec-2023        Price: US 2900 Onwards        Pages: 97
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global D-dimer market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Abbott Laboratories - F. Hoffman-La Roche - Beckman Coulter - Abbott - Bio/Data - Becton Dickinson - Sysmex - Siemens Healthcare - Trinit......
  • Global Human Coagulation Factor VII Professional Survey Report 2023, Forecast to 2028
    Published: 09-Nov-2023        Price: US 3280 Onwards        Pages: 104
    Factor VII (EC 3.4. 21.21, blood-coagulation factor VIIa, activated blood coagulation factor VII, formerly known as proconvertin) is one of the proteins that causes blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way,......
  • Global Human Coagulation Factor VII Market Research Report 2023, Forecast to 2028
    Published: 09-Nov-2023        Price: US 2680 Onwards        Pages: 167
    Factor VII (EC 3.4. 21.21, blood-coagulation factor VIIa, activated blood coagulation factor VII, formerly known as proconvertin) is one of the proteins that causes blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way,......
  • Global Human Coagulation Factor Viii Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 24-Aug-2023        Price: US 3380 Onwards        Pages: 98
    Market Overview of Global Human Coagulation Factor Viii market: According to our latest research, the global Human Coagulation Factor Viii market looks promising in the next 5 years. As of 2022, the global Human Coagulation Factor Viii market was estimated at USD 9757.48 million, and it's anticipated to reach USD 17207.33 million in 2028, with a CAGR of 9.92% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehe......
  • Global Coagulation Tests Market Insights, Forecast to 2029
    Published: 16-Jun-2023        Price: US 4900 Onwards        Pages: 109
    Globally, the hematology market is assessed as a mature market and is characterized by intense competition with a high demand for clinical coagulation tests. With the increase in the number of cardiovascular surgical procedures being performed, there has been a considerable need for coagulation testing. Today, an increasing number of patients are using anticoagulants after having a mechanical heart valve implantation performed, as well as to prevent coagulation accidents like pulmonary embolisms......
  • Global D-dimer Market Insights, Forecast to 2029
    Published: 14-Jun-2023        Price: US 4900 Onwards        Pages: 107
    The global D-dimer market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for D-dimer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. The China market for D-dimer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during......
  • Global Coagulation Tests Market Research Report 2023
    Published: 11-Apr-2023        Price: US 2900 Onwards        Pages: 86
    Globally, the hematology market is assessed as a mature market and is characterized by intense competition with a high demand for clinical coagulation tests. With the increase in the number of cardiovascular surgical procedures being performed, there has been a considerable need for coagulation testing. Today, an increasing number of patients are using anticoagulants after having a mechanical heart valve implantation performed, as well as to prevent coagulation accidents like pulmonary embolisms......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs